Profile data is unavailable for this security.
About the company
Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.
- Revenue in AUD (TTM)0.00
- Net income in AUD-1.31m
- Incorporated2010
- Employees--
- LocationAnatara Lifesciences Ltdc/- Perks, Level 8, 81 Flinders StreetADELAIDE 5000AustraliaAUS
- Phone+61 39824-5454
- Fax+61 73229-9949
- Websitehttps://anataralifesciences.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hydration Pharmaceuticals Co Ltd | 2.18m | -5.56m | 2.15m | -- | -- | 0.4998 | -- | 0.9892 | -0.022 | 0.0311 | 0.0077 | 0.01 | 0.3189 | 0.4291 | 1.99 | -- | -81.35 | -80.15 | -165.85 | -113.93 | 49.37 | 46.59 | -255.13 | -125.35 | 2.43 | -6.06 | 0.00 | -- | -25.48 | 1.58 | 21.50 | -- | -- | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.31m | 3.48m | -- | -- | 3.05 | -- | -- | -0.0059 | -0.0059 | 0.00 | 0.0036 | 0.00 | -- | -- | -- | -84.80 | -87.11 | -104.72 | -106.65 | -- | -- | -- | -- | -- | -281.03 | 0.00 | -- | -- | -- | -34.69 | -- | -- | -- |
| Acrux Ltd | 6.39m | -2.36m | 5.54m | 43.00 | -- | 4.62 | -- | 0.8674 | -0.0058 | -0.0058 | 0.0157 | 0.0029 | 1.02 | -- | 4.24 | -- | -37.61 | -48.30 | -59.34 | -61.75 | 44.09 | -- | -36.85 | -101.52 | -- | -3.32 | 0.6469 | -- | -44.08 | 3.32 | -2.50 | -- | -54.56 | -- |
| Zelira Therapeutics Ltd | 660.00 | -3.63m | 5.95m | 8.00 | -- | -- | -- | 9,013.00 | -0.3172 | -0.3172 | 0.00006 | -0.3749 | 0.0002 | 0.0102 | 0.003 | -- | -118.74 | -50.35 | -- | -56.97 | -1,236.36 | 43.05 | -583,283.30 | -2,379.12 | 0.0244 | -6.50 | -- | -- | -99.30 | -77.07 | 90.08 | -- | -- | -- |
| Nutritional Growth Solutions Ltd | 3.00m | -3.99m | 6.66m | -- | -- | -- | -- | 2.22 | -0.0432 | -0.0432 | 0.0321 | -0.0117 | 3.26 | 4.05 | 33.35 | -- | -433.20 | -130.49 | -- | -187.56 | 26.70 | 40.32 | -132.89 | -143.99 | 0.1206 | -19.99 | -- | -- | -16.86 | 15.95 | -0.2074 | -- | -- | -- |
| Calmer Co International Ltd | 8.10m | -3.37m | 9.18m | -- | -- | 48.23 | -- | 1.13 | -0.0011 | -0.0011 | 0.0027 | 0.00006 | 1.43 | 3.23 | 20.46 | -- | -59.49 | -109.82 | -91.22 | -197.50 | 40.64 | 41.18 | -41.62 | -128.71 | 1.16 | -7.40 | 0.9518 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Immuron Ltd | 7.48m | -4.65m | 9.80m | 7.00 | -- | 0.7494 | -- | 1.31 | -0.0187 | -0.0187 | 0.0295 | 0.04 | 0.5476 | 1.44 | 3.14 | 1,068,146.00 | -34.03 | -27.84 | -39.17 | -30.60 | 63.69 | 70.18 | -62.14 | -182.34 | 6.83 | -- | 0.00 | -- | 48.63 | 23.67 | 24.81 | -- | -- | -- |
| Tissue Repair Ltd | 3.65m | -3.85m | 9.98m | -- | -- | 0.8431 | -- | 2.74 | -0.0636 | -0.0636 | 0.0602 | 0.1957 | 0.2501 | -- | 49.00 | -- | -26.42 | -24.25 | -28.06 | -25.27 | -- | -- | -105.61 | -518.54 | 20.40 | -19.01 | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 10.12m | -- | -- | -- | -- | 1.65 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Firebrick Pharma Ltd | 159.94k | -2.45m | 14.64m | -- | -- | 7.53 | -- | 91.56 | -0.0106 | -0.0106 | 0.0007 | 0.0077 | 0.0777 | 0.4045 | 1.30 | -- | -119.12 | -98.41 | -142.70 | -109.28 | -9.34 | -- | -1,532.61 | -5,384.55 | 4.60 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| Oncosil Medical Ltd | 1.59m | -12.92m | 14.76m | 2.00 | -- | 3.08 | -- | 9.26 | -0.9425 | -0.9425 | 0.104 | 0.2028 | 0.1711 | -- | 3.47 | -- | -138.67 | -97.54 | -207.63 | -117.83 | -66.32 | -54.05 | -810.45 | -1,258.41 | -- | -386.47 | 0.011 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
